Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04449952 · ClinicalTrials.gov registry record · Phase 4

A Study of Mouth Rinses in Type 1 and Type 2 Diabetic Participants

A Phase 4 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

Completed
Registry status
Phase 4
Development phase
154
Enrollment target

NCT04449952 is a Phase 4 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 154 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04449952, a Phase 4 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

COMPLETED
Registry status
Phase 4
Development phase
154 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate mouth rinse formulations for oral soft tissue tolerance and efficacy in plaque/ gingivitis prevention/reduction in Type 1 and Type 2 diabetics when used twice daily as an adjunct to tooth brushing during a twelve-week treatment period.

Interventions

  • OTHER Colgate Cavity Protection Toothpaste
  • OTHER 5% Hydroalcohol Mouth Rinse
  • OTHER Listerine Cool Mint
  • OTHER Alcohol-Free Essential Oil Containing (AFEO) Mouth Rinse Lead Formula
  • DEVICE Concept Curve Winter Series Toothbrush

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2019-12-02
Est. Completion 2020-03-06
Phase Phase 4

What the Registry Record Tells You About NCT04449952

The ClinicalTrials.gov registry entry for NCT04449952 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Colgate Cavity Protection Toothpaste is the first listed.

NCT04449952 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04449952 about?

NCT04449952 is a clinical study titled "A Study of Mouth Rinses in Type 1 and Type 2 Diabetic Participants". The purpose of this study is to evaluate mouth rinse formulations for oral soft tissue tolerance and efficacy in plaque/ gingivitis prevention/reduction in Type 1 and Type 2 diabetics when used twice daily as an adjunct to tooth brushing during a twelve-week treatment period.

What is the current status of trial NCT04449952?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2019-12-02. Estimated completion is 2020-03-06.

What interventions are being tested in trial NCT04449952?

The interventions under investigation include: Colgate Cavity Protection Toothpaste (OTHER), 5% Hydroalcohol Mouth Rinse (OTHER), Listerine Cool Mint (OTHER), Alcohol-Free Essential Oil Containing (AFEO) Mouth Rinse Lead Formula (OTHER), Concept Curve Winter Series Toothbrush (DEVICE).

Who is sponsoring clinical trial NCT04449952?

This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.